An interventional study of Usual PT Care (UC) and BOOST-OA in Osteoarthritis, Knee, sponsored by VA Office of Research and Development. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Osteoarthritis, Knee by VA Office of Research and Development — 7 open to participants now, 8 under way, 2 of them phase 3. Osteoarthritis, Knee · VA Office of Research and Development.
Among the 17 studies in Osteoarthritis, Knee by VA Office of Research and Development, this one is the 3rd largest by planned enrollment of the 16 interventional ones that give a count, is one of 4 that started in 2026, is one of 10 with no phase, and was the 13th registered.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
Browse Osteoarthritis, Knee studies →7 of the 17 studies in Osteoarthritis, Knee by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:
VA Office of Research and Development · Sites in United States
Ages 45–75
VA Office of Research and Development · Sites in United States
VA Office of Research and Development · Sites in United States
Ages 30+
VA Office of Research and Development · Sites in United States
Ages 40–90
VA Office of Research and Development · Sites in United States
Ages 40+ · Healthy volunteers
By country, each count listing its studies:
Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 3 · Phase 3 2
First in 2004; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 360 is above the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 85 across the 16 interventional studies, 47 across the 1 observational. Of the 9 that completed or were terminated, 6 (67%) have results posted.
This tab as a report to print or save as PDF → With an account.
VA Office of Research and Development is the lead sponsor of 1,774 studies on the registry; 394 are open to participants now.
Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.
2 of the studies in Osteoarthritis, Knee by VA Office of Research and Development that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07481474VA Office of Research and DevelopmentPilot and Feasibility Study of Anti-CD14 for the Treatment of Knee Osteoarthritis | 2027-06-01 |
| NCT07580222VA Office of Research and DevelopmentMobile Technology to Measure Knee Health in Osteoarthritis | 2027-09-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 17 studies in Osteoarthritis, Knee by VA Office of Research and Development, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This project, conducted within the Department of Veterans Affairs Healthcare System (VHA), will test the effectiveness of an intervention to improve adherence to home exercise among Veterans receiving physical therapy (PT) for knee osteoarthritis (OA). The intervention, "Boosting Exercise Adherence in Knee Osteoarthritis" (BOOST-OA), has two phases. During the initiation phase (first 3 months of PT care), patients will receive tools and activities to address outcome expectations, action self-efficacy, goal-setting and monitoring. During the behavior maintenance phase (starting after PT care and continuing for 9 months), patients will receive health coaching calls that address satisfaction with outcomes, relapse prevention planning and independent monitoring. There are three main study aims: (1) examine improvements in patient outcomes, such as physical function, following BOOST-OA; (2) explore patient characteristics that lead to difference in reported improvements; and (3) interview participants and clinicians about their experience with BOOST-OA to inform future implementation.
In this project, the investigators will test the effectiveness of a theoretically-informed, scalable intervention to enhance adherence to home exercise among Veterans receiving PT for knee OA. "Boosting Exercise Adherence in Knee Osteoarthritis" (BOOST-OA) includes components that address both exercise behavior initiation (conducted in conjunction with the PT episode of care) and maintenance (conducted after completion of PT care). Specifically, BOOST-OA includes: 1) Tools and activities woven into PT visits that address outcome expectations, action self-efficacy, goal-setting and monitoring (3-month behavior initiation phase) and 2) Health coaching calls that address satisfaction with outcomes, relapse prevention planning and independent monitoring (9-month behavior maintenance phase). This project is being conducted within the Department of Veterans Affairs Healthcare system (VHA). Specific aims are:
The criteria were revised on the registry on Nov 17, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
UC will be delivered by trained clinicians at participating sites. The study team will provide clinicians with guidance and training to standardize core aspects of physical therapy (PT), aligned with best practice recommendations. Clinicians must provide enrolled Veterans with at least 4 PT visits, spaced at least weekly so that Veterans can practice home exercise and receive guidance in exercise progression. All PT visits must be completed within 3 months.
Behavioral: Usual PT Care (UC)
BOOST-OA includes components that are integrated into physical therapy (PT) visits (concurrent), focused on behavior initiation, as well as components that occur after PT visits have ended (sequential), focused on behavior maintenance. Concurrent components will be delivered in conjunction with usual care PT visits. Clinicians must provide enrolled Veterans with at least 4 PT visits, spaced at least weekly. PT visits must be also completed within 3 months. Sequential components will be delivered by a health coach via phone or video. Health coach sessions will be conducted every other week for the first 2 months (months 4-5), monthly for an additional 3 months (months 6- 8), and every other month for the last 4 months (months 9-12; 9 total contacts). Calls will address strengthening and stretching exercises (≥3 times per week), as well as overall physical activity (e.g., minutes / steps).
Behavioral: BOOST-OA
UC will be delivered by trained clinicians at participating sites. The study team will provide clinicians with guidance and training to standardize core aspects of physical therapy (PT), aligned with best practice recommendations. Clinicians must provide enrolled Veterans with at least 4 PT visits, spaced at least weekly so that Veterans can practice home exercise and receive guidance in exercise progression. All PT visits must be completed within 3 months.
BOOST-OA includes components that are integrated into physical therapy (PT) visits (concurrent), focused on behavior initiation, as well as components that occur after PT visits have ended (sequential), focused on behavior maintenance. Concurrent components will be delivered in conjunction with usual care PT visits. Clinicians must provide enrolled Veterans with at least 4 PT visits, spaced at least weekly. PT visits must be also completed within 3 months. Sequential components will be delivered by a health coach via phone or video. Health coach sessions will be conducted every other week for the first 2 months (months 4-5), monthly for an additional 3 months (months 6- 8), and every other month for the last 4 months (months 9-12; 9 total contacts). Calls will address strengthening and stretching exercises (≥3 times per week), as well as overall physical activity (e.g., minutes / steps).
Western Ontario and McMaster Universities Arthritis Index (WOMAC) Physical Function Subscale
The investigators selected physical function as the primary outcome because of its high importance to individuals with knee osteoarthritis (OA) and its relevance for PT and exercise-based interventions. The WOMAC has been used widely in the context of clinical trials for knee OA and has well established psychometric properties including reliability, construct validity, internal consistency, and sensitivity to change in the context of behavioral interventions for knee OA. The WOMAC function subscale consists of 17 items rated on a Likert scale of 0 (no difficulty) to 4 (extreme difficulty).
Time frame: Baseline
Western Ontario and McMaster Universities Arthritis Index (WOMAC) Physical Function Subscale
The investigators selected physical function as the primary outcome because of its high importance to individuals with knee osteoarthritis (OA) and its relevance for PT and exercise-based interventions. The WOMAC has been used widely in the context of clinical trials for knee OA and has well established psychometric properties including reliability, construct validity, internal consistency, and sensitivity to change in the context of behavioral interventions for knee OA. The WOMAC function subscale consists of 17 items rated on a Likert scale of 0 (no difficulty) to 4 (extreme difficulty).
Time frame: Change from baseline to 3-months
Western Ontario and McMaster Universities Arthritis Index (WOMAC) Physical Function Subscale
The investigators selected physical function as the primary outcome because of its high importance to individuals with knee osteoarthritis (OA) and its relevance for PT and exercise-based interventions. The WOMAC has been used widely in the context of clinical trials for knee OA and has well established psychometric properties including reliability, construct validity, internal consistency, and sensitivity to change in the context of behavioral interventions for knee OA. The WOMAC function subscale consists of 17 items rated on a Likert scale of 0 (no difficulty) to 4 (extreme difficulty).
Time frame: Change from baseline to 12-months (primary outcome time point)
Western Ontario and McMaster Universities Arthritis Index (WOMAC) Physical Function Subscale
The investigators selected physical function as the primary outcome because of its high importance to individuals with knee osteoarthritis (OA) and its relevance for PT and exercise-based interventions. The WOMAC has been used widely in the context of clinical trials for knee OA and has well established psychometric properties including reliability, construct validity, internal consistency, and sensitivity to change in the context of behavioral interventions for knee OA. The WOMAC function subscale consists of 17 items rated on a Likert scale of 0 (no difficulty) to 4 (extreme difficulty).
Time frame: Change from baseline to 18-months
Western Ontario and McMaster Universities Arthritis Index (WOMAC) Physical Function Subscale
The investigators selected physical function as the primary outcome because of its high importance to individuals with knee osteoarthritis (OA) and its relevance for PT and exercise-based interventions. The WOMAC has been used widely in the context of clinical trials for knee OA and has well established psychometric properties including reliability, construct validity, internal consistency, and sensitivity to change in the context of behavioral interventions for knee OA. The WOMAC function subscale consists of 17 items rated on a Likert scale of 0 (no difficulty) to 4 (extreme difficulty).
Time frame: Change from baseline to 24-months
Patient Specific Functional Scale
This modified version of the Patient Specific Functional Scale will ask participants to identify one important activity they are unable to do or are having difficulty with as a result of their knee osteoarthritis (OA). They then rate their ability to perform the identified activity from 0=unable to perform to 10=able to perform at the same level as before having knee OA.
Time frame: Baseline
30-second Chair Stand
The number of times that a participant can stand up from a seated position and sit back down in 30-seconds.
Time frame: Baseline
2-minute Step Test
The number of times a participant can step in place in a 2-minute period.
Time frame: Baseline
Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain subscale
In addition to the WOMAC function subscale, the investigators will assess the WOMAC pain subscale (score range 0-20, higher scores indicate greater pain severity).
Time frame: Baseline
Western Ontario and McMaster Universities Arthritis Index (WOMAC) Total Score
The investigators will combine WOMAC subscales to calculate a total score (score range 0-96, higher scores indicate greater pain, stiffness, and functional limitation).
Time frame: Baseline
Patient Specific Functional Scale
This modified version of the Patient Specific Functional Scale will ask participants to identify one important activity they are unable to do or are having difficulty with as a result of their knee osteoarthritis (OA). They then rate their ability to perform the identified activity from 0=unable to perform to 10=able to perform at the same level as before having knee OA.
Time frame: Change from baseline to 3-months
Minutes of physical activity
The investigators will utilize validated algorithms to calculate average minutes of light and moderate-to-vigorous physical activity per day assessed by accelerometer.
Time frame: Baseline
Patient Specific Functional Scale
This modified version of the Patient Specific Functional Scale will ask participants to identify one important activity they are unable to do or are having difficulty with as a result of their knee osteoarthritis (OA). They then rate their ability to perform the identified activity from 0=unable to perform to 10=able to perform at the same level as before having knee OA.
Time frame: Change from baseline to 12-months (primary outcome time point)
Patient Specific Functional Scale
This modified version of the Patient Specific Functional Scale will ask participants to identify one important activity they are unable to do or are having difficulty with as a result of their knee osteoarthritis (OA). They then rate their ability to perform the identified activity from 0=unable to perform to 10=able to perform at the same level as before having knee OA.
Time frame: Change from baseline to 18-months
Patient Specific Functional Scale
This modified version of the Patient Specific Functional Scale will ask participants to identify one important activity they are unable to do or are having difficulty with as a result of their knee osteoarthritis (OA). They then rate their ability to perform the identified activity from 0=unable to perform to 10=able to perform at the same level as before having knee OA.
Time frame: Change from baseline to 24-months
Minutes of physical activity
The investigators will utilize validated algorithms to calculate average minutes of light and moderate-to-vigorous physical activity per day assessed by accelerometer.
Time frame: Change from baseline to 12-months (primary outcome time point)
Minutes of physical activity
The investigators will utilize validated algorithms to calculate average minutes of light and moderate-to-vigorous physical activity per day assessed by accelerometer.
Time frame: Change from baseline to 24-months
30-second Chair Stand
The number of times that a participant can stand up from a seated position and sit back down in 30-seconds.
Time frame: Change from baseline to 3-months
30-second Chair Stand
The number of times that a participant can stand up from a seated position and sit back down in 30-seconds.
Time frame: Change from baseline to 12-months (primary outcome time point)
30-second Chair Stand
The number of times that a participant can stand up from a seated position and sit back down in 30-seconds.
Time frame: Change from baseline to 18-months
30-second Chair Stand
The number of times that a participant can stand up from a seated position and sit back down in 30-seconds.
Time frame: Change from baseline to 24-months
2-minute Step Test
The number of times a participant can step in place in a 2-minute period.
Time frame: Change from baseline to 3-months
2-minute Step Test
The number of times a participant can step in place in a 2-minute period.
Time frame: Change from baseline to 12-months (primary outcome time point)
2-minute Step Test
The number of times a participant can step in place in a 2-minute period.
Time frame: Change from baseline to 18-months
2-minute Step Test
The number of times a participant can step in place in a 2-minute period.
Time frame: Change from baseline to 24-months
Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain subscale
In addition to the WOMAC function subscale, the investigators will assess the WOMAC pain subscale (score range 0-20, higher scores indicate greater pain severity).
Time frame: Change from baseline to 3-months
Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain subscale
In addition to the WOMAC function subscale, the investigators will assess the WOMAC pain subscale (score range 0-20, higher scores indicate greater pain severity).
Time frame: Change from baseline to 12-months (primary outcome time point)
Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain subscale
In addition to the WOMAC function subscale, the investigators will assess the WOMAC pain subscale (score range 0-20, higher scores indicate greater pain severity).
Time frame: Change from baseline to 18-months
Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain subscale
In addition to the WOMAC function subscale, the investigators will assess the WOMAC pain subscale (score range 0-20, higher scores indicate greater pain severity).
Time frame: Change from baseline to 24-months
Western Ontario and McMaster Universities Arthritis Index (WOMAC) Total Score
The investigators will combine WOMAC subscales to calculate a total score (score range 0-96, higher scores indicate greater pain, stiffness, and functional limitation).
Time frame: Change from baseline to 3-months
Western Ontario and McMaster Universities Arthritis Index (WOMAC) Total Score
The investigators will combine WOMAC subscales to calculate a total score (score range 0-96, higher scores indicate greater pain, stiffness, and functional limitation).
Time frame: Change from baseline to 12-months (primary outcome time point)
Western Ontario and McMaster Universities Arthritis Index (WOMAC) Total Score
The investigators will combine WOMAC subscales to calculate a total score (score range 0-96, higher scores indicate greater pain, stiffness, and functional limitation).
Time frame: Change from baseline to 18-months
Western Ontario and McMaster Universities Arthritis Index (WOMAC) Total Score
The investigators will combine WOMAC subscales to calculate a total score (score range 0-96, higher scores indicate greater pain, stiffness, and functional limitation).
Time frame: Change from baseline to 24-months
Average Step Count
The investigators will utilize validated algorithms to calculate average steps per day assessed by accelerometer.
Time frame: Baseline
Average Step Count
The investigators will utilize validated algorithms to calculate average steps per day assessed by accelerometer.
Time frame: Change from baseline to 12-months (primary outcome time point)
Average Step Count
The investigators will utilize validated algorithms to calculate average steps per day assessed by accelerometer.
Time frame: Change from baseline to 24-months
Plan to share: Yes — A de-identified, anonymized dataset will be available upon request, as allowable under the regulations and policies of study sponsors. Prior to distribution, a local privacy officer and study statistician will certify that the dataset contains no protected health information (PHI). Data will be provided to requestor in electronic format. Sufficient data and descriptors will be made available to duplicate statistical analysis and confirm conclusions in publication. No data or statistical code that could lead to re-identification of individuals will be released. Data will only be released per appropriate authorizations or agreements. Written agreements will specify that recipients are prohibited from taking steps to re-identify any individual whose data are included in the dataset
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: Deidentified data will be made available after study completion and as allowable by current VA policies.
Access criteria: Data will only be released per appropriate authorizations or agreements. Written agreements will specify that recipients are prohibited from taking steps to re- identify any individual whose data are included in the dataset.
No publications or documents are linked to this record.
Started Nov 2026 (actual). Primary completion is estimated for Dec 2030, 49 months after the start.
Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 49 months is above that.
Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.
Start moved 3 times since we started tracking on Sep 25, 2026: Sep 2026 → Nov 2026, last on Nov 17, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
VA Office of Research and Development →